Xeris Biopharma Holdings, Inc.XERSNASDAQ
LOADING
|||
Switch Symbol:
Cash Flow Performance
Trending higher, above historical average, structural decline.
Left:
||||
Free cash flow yield
Latest
-7.61%
↑ 80% above average
Average (8y)
-38.69%
Historical baseline
Range
High:-7.61%
Low:-61.84%
CAGR
-19.5%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -7.61% | +50.1% |
| 2023 | -15.23% | +73.4% |
| 2022 | -57.33% | -28.4% |
| 2021 | -44.66% | +3.0% |
| 2020 | -46.05% | -4.7% |
| 2019 | -43.97% | -55.8% |
| 2018 | -28.22% | +54.4% |
| 2017 | -61.84% | -42.9% |
| 2016 | -43.28% | - |